Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

Objective: Although Parkinson disease with dementia (PDD) and dementia with Lewy bodies (DLB) show a wide clinical and neuropathologic overlap, they are differentiated according to the order and latency of cognitive and motor symptom appearance. Whether both are distinct disease entities is an ongoing controversy. Therefore, we directly compared patients with DLB and PDD with multitracer PET. Methods: PET with 18fluorodopa (FDOPA), N-11C-methyl-4-piperidyl acetate (MP4A), and 18fluorodeoxyglucose (FDG) was performed in 8 patients with PDD, 6 patients with DLB, and 9 patients with PD without dementia vs age-matched controls. Data were analyzed with voxel-based statistical parametric mapping and region of interest–based statistics. Results: We found a reduced FDOPA uptake in the striatum and in limbic and associative prefrontal areas in all patient groups. Patients with PDD and patients with DLB showed a severe MP4A and FDG binding reduction in the neocortex with increasing signal diminution from frontal to occipital regions. Significant differences between PDD and DLB were not found in any of the radioligands used. Patients with PD without dementia had a mild cholinergic deficit and no FDG reductions vs controls. Conclusions: Patients with dementia with Lewy bodies and Parkinson disease dementia share the same dopaminergic and cholinergic deficit profile in the brain and seem to represent 2 sides of the same coin in a continuum of Lewy body diseases. Cholinergic deficits seem to be crucial for the development of dementia in addition to motor symptoms. The spatial congruence of cholinergic deficits and energy hypometabolism argues for cortical deafferentation due to the degeneration of projection fibers from the basal forebrain.

[1]  D J Brooks,et al.  DLB and PDD boundary issues , 2007, Neurology.

[2]  B. Schmand,et al.  Cognitive profile of patients with newly diagnosed Parkinson disease , 2005, Neurology.

[3]  Karl Herholz,et al.  In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease , 2004, NeuroImage.

[4]  Keith A. Johnson,et al.  Imaging amyloid deposition in Lewy body diseases , 2008, Neurology.

[5]  Karl J. Friston,et al.  Statistical parametric mapping , 2013 .

[6]  Michael L. Kramer,et al.  Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  C. Rowe,et al.  Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  N. Bohnen,et al.  Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.

[9]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[10]  F. Mastaglia,et al.  Prevalence of amyloid-beta deposition in the cerebral cortex in Parkinson's disease. , 2003, Movement disorders : official journal of the Movement Disorder Society.

[11]  N. Bohnen,et al.  Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.

[12]  P. Hof,et al.  Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.

[13]  E. Sariban,et al.  Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium , 1998, Bone Marrow Transplantation.

[14]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  R. Hilker,et al.  Dementia in Parkinson disease , 2005, Neurology.

[16]  H. Arai,et al.  18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies , 2000, Neurology.

[17]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[18]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[19]  E. Perry,et al.  Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology , 1999, Journal of Neural Transmission.

[20]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[21]  E. Perry,et al.  Differences in neuropathologic characteristics across the Lewy body dementia spectrum , 2006, Neurology.

[22]  Albert Gjedde,et al.  Oxidative and Nonoxidative Metabolism of Excited Neurons and Astrocytes , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  A. Tröster,et al.  Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease , 2003, Journal of the International Neuropsychological Society.

[24]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[25]  A. Lees,et al.  Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients , 2008, Acta Neuropathologica.

[26]  W D Heiss,et al.  Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene , 2001, Annals of neurology.

[27]  K Wienhard,et al.  Estimation of Local Cerebral Glucose Utilization by Positron Emission Tomography of [18F]2-Fluoro-2-Deoxy-D-Glucose: A Critical Appraisal of Optimization Procedures , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  T. Suhara,et al.  Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET , 2009, Neuroscience Research.

[29]  F. Mastaglia,et al.  Prevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease , 2003 .

[30]  M. Lercher,et al.  PET functional parametric images of acetylcholine esterase activity without blood sampling , 2002 .

[31]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[32]  Matthias Reimold,et al.  [11C]PIB binding in Parkinson's disease dementia , 2008, NeuroImage.

[33]  Dag Aarsland,et al.  Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity? , 2004, Journal of geriatric psychiatry and neurology.

[34]  J. Trojanowski,et al.  Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses , 2003, Annals of the New York Academy of Sciences.

[35]  E. Perry,et al.  Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems , 2008, Journal of Neural Transmission.

[36]  C. Rowe,et al.  Imaging β-amyloid burden in aging and dementia , 2007, Neurology.

[37]  Dag Aarsland,et al.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. , 2004, Archives of neurology.

[38]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[39]  R. Martínez-Murillo,et al.  Distribution of catecholaminergic afferent fibres in the rat globus pallidus and their relations with cholinergic neurons , 1998, Journal of Chemical Neuroanatomy.

[40]  Peter Herscovitch,et al.  Brain imaging using PET , 2002 .

[41]  Michael L. Kramer,et al.  Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.

[42]  J. O'Brien,et al.  Functional Imaging in Parkinson’s Disease and Dementia with Lewy Bodies , 2004, Journal of geriatric psychiatry and neurology.